In millions, except per share items | Dec-31-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Research and development | | | | | | 1,277.7 | | |
Product sales | | | 2.4 | 2.3 | 2.6 | 3.1 | 3.0 | 3.5 |
License fee and other revenues | | | 0.3 | 0.4 | 1.3 | 4.6 | 0.1 | 28.4 |
Other | | | 0.4 | 0.6 | 1.8 | | 1.8 | 0.8 |
Total revenues [+] | 0.3 | 2.2 | 3.1 | 3.2 | 5.7 | 9.0 | 5.0 | 32.7 |
Licensing | | | 0.3 | 0.4 | 1.3 | 4.6 | 0.1 | 28.4 |
Royalties | | | | | | 1,277.7 | | |
Products | | | 2.4 | 2.3 | 2.6 | 3.1 | 3.0 | 3.5 |
Grants | | | 0.4 | 0.6 | | 1.3 | 1.8 | 0.8 |
Net interest income | -40.3 | -23.3 | -5.5 | -5.5 | | | | |
Revenue growth [+] | | -30.3% | -4.4% | -42.8% | -37.5% | 82.2% | -84.8% | 122.5% |
Product sales | | | 8.1% | -14.6% | -15.7% | 5.0% | -15.0% | -2.5% |
License fee and other revenues | | | -26.5% | -69.0% | -73.0% | 3550.0% | -99.6% | 180.6% |
Cost of goods sold [+] | 0.0 | 0.6 | 0.5 | 1.2 | 0.3 | 1.5 | 0.4 | 0.4 |
Cost of product sales | | | | | | 0.3 | | |
Cost of licensing | | | | | | 1.2 | | |
Gross profit | 0.3 | 1.5 | 2.6 | 2.1 | 5.4 | 7.5 | 4.6 | 32.3 |
Gross margin | 100.0% | 71.6% | 84.4% | 64.1% | 95.3% | 83.1% | 92.1% | 98.7% |
Selling, general and administrative [+] | 70.3 | 43.3 | 30.0 | 7.6 | 9.9 | 9.4 | 7.0 | 6.6 |
Sales and marketing | 26.5 | 6.8 | 0.9 | 1.0 | 0.8 | 1.1 | 0.8 | 0.8 |
General and administrative | 43.8 | 36.5 | 29.1 | 6.6 | 9.1 | 8.3 | 6.2 | 5.8 |
Research and development | 254.9 | 99.3 | 51.8 | 53.5 | 41.7 | 33.7 | 28.4 | 24.3 |
Other operating expenses | | -6.6 | | | | | -0.1 | |
EBITDA [+] | -321.0 | -133.1 | -78.2 | -58.3 | -45.6 | -35.0 | -29.6 | 2.9 |
EBITDA growth | | 70.2% | 34.2% | 27.7% | 30.4% | 18.2% | -1107.6% | -117.9% |
EBITDA margin | -108819.0% | -6174.0% | -2530.6% | -1802.2% | -807.4% | -387.2% | -596.9% | 9.0% |
Depreciation and amortization | 3.8 | 1.3 | 0.9 | 0.7 | 0.6 | 0.6 | 1.0 | 1.5 |
EBIT [+] | -324.8 | -134.4 | -79.1 | -59.0 | -46.2 | -35.6 | -30.7 | 1.4 |
EBIT growth | | 69.8% | 34.1% | 27.7% | 29.9% | 16.1% | -2224.9% | -108.1% |
EBIT margin | -110114.6% | -6234.2% | -2560.4% | -1825.0% | -817.6% | -393.5% | -617.8% | 4.4% |
Non-recurring items [+] | | 6.6 | | | | | 0.1 | |
Unusual expense | | 6.6 | | | | | | |
Interest expense, net [+] | -7.9 | -5.5 | -0.4 | -0.3 | 1.8 | -0.1 | 0.0 | 0.0 |
Interest expense | 39.9 | 19.8 | | | 2.1 | | | |
Interest income | 7.9 | 5.5 | 0.4 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 |
Other income (expense), net [+] | -0.4 | -118.4 | -74.5 | -5.5 | 0.0 | 0.0 | 19.3 | 0.0 |
Litigation settlement | | | | | | | 16.7 | |
Gain (loss) on debt retirement | | -13.0 | | | | | | |
Unrealized gain/loss on derivatives | | -108.6 | -61.1 | | | | | |
Gain (loss) on foreign currency transactions | | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Change in fair value of warrants | | -108.6 | -61.1 | | | | | |
Pre-tax income | -357.3 | -273.7 | -153.2 | -64.2 | -48.1 | -35.5 | -11.4 | 1.5 |
Income taxes | 0.0 | 0.2 | 0.0 | -5.1 | 0.1 | 0.0 | 0.0 | 0.2 |
Tax rate | 0.0% | | | 7.9% | | | | 14.2% |
Minority interest | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
Net income | -357.2 | -273.8 | -153.2 | -59.0 | -48.0 | -35.4 | -11.4 | 1.4 |
Net margin | -121081.4% | -12701.2% | -4956.1% | -1825.9% | -849.1% | -391.8% | -229.4% | 4.2% |
|
Basic EPS [+] | ($1.84) | ($1.78) | ($1.47) | ($0.62) | ($0.51) | ($0.42) | ($0.15) | $0.02 |
Growth | | 21.7% | 135.3% | 21.1% | 22.9% | 187.0% | -898.6% | -109.7% |
Diluted EPS [+] | ($1.84) | ($1.78) | ($1.47) | ($0.62) | ($0.51) | ($0.42) | ($0.15) | $0.02 |
Growth | | 21.7% | 135.3% | 21.1% | 22.9% | 187.0% | -906.0% | -109.6% |
|
Shares outstanding (basic) [+] | 193.6 | 153.5 | 104.5 | 94.8 | 93.3 | 84.6 | 78.0 | 75.5 |
Growth | | 46.8% | 10.3% | 1.6% | 10.3% | 8.4% | 3.4% | 0.2% |
Shares outstanding (diluted) [+] | 193.6 | 153.5 | 104.5 | 94.8 | 93.3 | 84.6 | 78.0 | 76.2 |
Growth | | 46.8% | 10.3% | 1.6% | 10.3% | 8.4% | 2.4% | 1.1% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |